#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukoencephalopathy Endocrine ophthalmopathy Follicle centre lymphoma follicular grade I, II – III Chronic graft versus host disease T-cell lymphoma Warm autoimmune haemolytic anaemia Ovarian epithelial cancer Waldenstrom's macroglobulinaemia refractory Transplant rejection Dementia Alzheimer's type Short-bowel syndrome Heart disease congenital Rectal cancer Stress cardiomyopathy Marginal zone lymphoma refractory More trials…

    Learn about Rare Diseases

    Phenylketonuria – Basic Information Marginal zone lymphoma refractory – Life with Disease Burkitt’s lymphoma – Life with Disease Behcet’s syndrome – Trials in Disease Idiopathic inflammatory myopathy – Diagnostics Erdheim-Chester disease – Treatment Chondrosarcoma metastatic – Trials in Disease Hereditary motor and sensory neuropathy – Trials in Disease Angelman’s syndrome – Life with Disease Glycogen storage disease type I – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Highly Refined Fish Oil AB521 Lamivudine Daplusiran ALPROSTADIL Candesartan Cilexetil ANXV Evx-01 Ceritinib Nizatidine Ubiquinol Azelastine RNK001 Furosemide VHB937 Pc14586 Cemiplimab AZD0022 Dexamethasone Isonicotinate 64CU-PSMA I&T More therapies…

    Learn about Your Condition

    Renal cancer Lung transplant rejection Staphylococcal bacteraemia Biliary cancer metastatic Infertility male Muscular dystrophy Endocrine disorder Tonsillitis Genital infection female Mental disorder Testicular leiomyosarcoma Bone marrow disorder Nodular melanoma Leiomyosarcoma Lung adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Small cell lung cancer

  • Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • BNT327
    • Carboplatin
    France Germany Italy The Netherlands Poland Romania +1

  • Study on MK-6070 and Ifinatamab Deruxtecan for Patients with Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • GOCATAMIG
    • Ifinatamab Deruxtecan
    • Durvalumab
    Spain

  • Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Topotecan
    Austria Belgium Czechia France Germany Greece +7

  • Study of Atezolizumab and Chemotherapy for Patients with Relapsed Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Atezolizumab
    Italy

  • Study on Niraparib with Immunotherapy for Patients with SLFN11-Positive Extensive-Stage Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Atezolizumab
    • Durvalumab
    France Germany Italy Romania Spain

  • Study on BI 764532 for Patients with Relapsed or Refractory Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

    Recruiting

    2 1 1
    Investigated Drugs:
    • Bi 764532
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    Belgium Bulgaria France Germany Italy Poland +2
Previous Page
1 2 3 4 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!